ZA885967B - Elaboration of host defense mediators into biological fluids by systemic dsrna treatment - Google Patents

Elaboration of host defense mediators into biological fluids by systemic dsrna treatment

Info

Publication number
ZA885967B
ZA885967B ZA885967A ZA885967A ZA885967B ZA 885967 B ZA885967 B ZA 885967B ZA 885967 A ZA885967 A ZA 885967A ZA 885967 A ZA885967 A ZA 885967A ZA 885967 B ZA885967 B ZA 885967B
Authority
ZA
South Africa
Prior art keywords
biological fluids
elaboration
host defense
various
systemic
Prior art date
Application number
ZA885967A
Other languages
English (en)
Inventor
William A Carter
A Carter William
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of ZA885967B publication Critical patent/ZA885967B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA885967A 1987-08-12 1988-08-12 Elaboration of host defense mediators into biological fluids by systemic dsrna treatment ZA885967B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8422787A 1987-08-12 1987-08-12

Publications (1)

Publication Number Publication Date
ZA885967B true ZA885967B (en) 1989-07-26

Family

ID=22183617

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA885967A ZA885967B (en) 1987-08-12 1988-08-12 Elaboration of host defense mediators into biological fluids by systemic dsrna treatment

Country Status (19)

Country Link
EP (1) EP0308066B1 (no)
JP (1) JPH01131119A (no)
KR (1) KR0131879B1 (no)
CN (1) CN1050995C (no)
AT (1) ATE132041T1 (no)
AU (3) AU2053588A (no)
CA (1) CA1327002C (no)
DE (1) DE3854829T2 (no)
DK (1) DK449888A (no)
FI (1) FI883763A (no)
HU (1) HUT47854A (no)
IE (1) IE72103B1 (no)
IL (1) IL87413A0 (no)
NO (1) NO883594L (no)
NZ (1) NZ225799A (no)
OA (1) OA08901A (no)
PT (1) PT88266B (no)
RU (1) RU1834663C (no)
ZA (1) ZA885967B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
EP0306347B1 (en) * 1987-09-04 1995-05-10 Hem Pharmaceuticals Corp. Diagnosis of double-stranded RNA deficiency states
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
EP0378621A4 (en) * 1988-05-23 1991-08-28 Steffen Gay Diagnostics and therapy for rheumatoid arthritis
JPH04507083A (ja) * 1989-05-19 1992-12-10 ヘム・リサーチ・インコーポレーテッド 規定された構造の短い治療用ｄｓＲＮＡ
AU6740590A (en) * 1989-10-11 1991-05-16 Hem Research, Inc. Protection from shock subsequent to injury by double-stranded rnas
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
JP3256222B2 (ja) * 1989-10-16 2002-02-12 エイチイーエム リサーチ，インコーポレイティド 全身性免疫機能不全に関連する神経―知覚疾患の診断及び治療
EP0654998A1 (en) * 1991-09-26 1995-05-31 Hem Pharmaceuticals Corp. METHOD OF NEUTRALIZING IL-1 USING dsRNAs
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
JP4187413B2 (ja) 1998-03-20 2008-11-26 コモンウェルス サイエンティフィック アンドインダストリアル リサーチ オーガナイゼーション 遺伝子発現の制御
WO2000044914A1 (en) 1999-01-28 2000-08-03 Medical College Of Georgia Research Institute, Inc. Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
EP1229134A3 (en) 2001-01-31 2004-01-28 Nucleonics, Inc Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
ES2397060T3 (es) * 2002-04-18 2013-03-04 Opko Pharmaceuticals, Llc Medios y métodos para la modulación específica de genes diana en el ojo
US7148342B2 (en) 2002-07-24 2006-12-12 The Trustees Of The University Of Pennyslvania Compositions and methods for sirna inhibition of angiogenesis
EP1551424B1 (en) 2002-09-04 2015-07-01 Arrowhead Research Corporation Treatment of chronic neuropathic pain by admistration of dsrna
EP2134172A4 (en) * 2007-03-05 2011-06-01 Univ Utah State RESTRICTIVE AGONIST OF THE TOLL LIKE RECEPTOR 3
US8470792B2 (en) 2008-12-04 2013-06-25 Opko Pharmaceuticals, Llc. Compositions and methods for selective inhibition of VEGF
CN109355334A (zh) * 2018-12-06 2019-02-19 江苏省农业科学院 一种制备聚肌胞的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles

Also Published As

Publication number Publication date
EP0308066B1 (en) 1995-12-27
PT88266A (pt) 1989-06-30
AU2053588A (en) 1989-04-20
NZ225799A (en) 1991-04-26
IL87413A0 (en) 1989-01-31
AU1001595A (en) 1995-02-23
DK449888A (da) 1989-02-13
DK449888D0 (da) 1988-08-11
KR890003402A (ko) 1989-04-14
EP0308066A3 (en) 1991-01-16
JPH01131119A (ja) 1989-05-24
CN1032740A (zh) 1989-05-10
IE72103B1 (en) 1997-03-12
FI883763A (fi) 1989-02-13
RU1834663C (ru) 1993-08-15
IE882399L (en) 1989-02-12
HUT47854A (en) 1989-04-28
CA1327002C (en) 1994-02-15
FI883763A0 (fi) 1988-08-12
DE3854829T2 (de) 1996-08-14
NO883594D0 (no) 1988-08-12
EP0308066A2 (en) 1989-03-22
ATE132041T1 (de) 1996-01-15
KR0131879B1 (ko) 1998-04-17
OA08901A (en) 1989-10-31
AU1736792A (en) 1992-07-30
NO883594L (no) 1989-02-13
CN1050995C (zh) 2000-04-05
DE3854829D1 (de) 1996-02-08
PT88266B (pt) 1995-05-04

Similar Documents

Publication Publication Date Title
ZA885967B (en) Elaboration of host defense mediators into biological fluids by systemic dsrna treatment
KR900700094A (ko) 지방산과 모노글리세라이드의 항비루스 및 항세균 활성
DK345484A (da) Projektil til ildvaaben
OA08724A (fr) Treatment of human viral infections by dsRNA combined with viral inhibitors.
EP0400958A3 (en) Live vaccines
IE862276L (en) PREVENTION AND TREATMENT OF AIDS WITH dsRNA
EP0500893A4 (en) Preservation of blood, tissues and biological fluids
EP0221611A3 (en) Antimicrobial agents and process for their manufacture
BR0112919A (pt) Uso de óleos essenciais para combater infecção do trato gi por organismos semelhantes a helicobacter
ES2083396T3 (es) Acidos fenilalcan(en)oicos.
AU5684286A (en) Use of an aqueous, stabilised chlorite matrix solution for infectious conditions
ES2053039T3 (es) Procedimiento para impedir el cambio de color de los alimentos.
DE3767308D1 (de) Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels.
AU6751294A (en) Protection from shock subsequent to injury by double-standard RNAs
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
ES2046246T3 (es) Composicion terapeutica para combatir el sida.
KR900017587A (ko) 바이러스 감염증 치료제의 제조를 위한 티아졸 유도체 티프로티모드의 용도
DE69110470D1 (de) Herstellung von erhöhten Biokontrollwirkstoffen.
Wargo Interaction of stress and secondary organisms in decline of forest trees.
SU1727820A1 (ru) Способ стимул ции сперматогенеза у быков
Ohbuchi Negativity Bias
AU4849897A (en) Elaboration of host defense mediators into biological fluids by systemic dsRNA treatment
AU2211592A (en) Method of treatment for latent virus infection
Pavlovskis et al. Experimental Pseudomonas aeruginosa infections in burned mice and rats: Description of a model.
RU92015278A (ru) Средство, стабилизирующее витамины групп с, р, в и а и повышающее биологическую ценность пищевых продуктов